Key result
US cardiovascular mortality decline slows dramatically in 2011, coinciding with rising heart failure prevalence.
Why the study?
The decline in CVD mortality slowed dramatically in 2011 while HF prevalence simultaneously increased and is projected to rise.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The shifts in age distribution, worsening in mortality rates, widening racial and ethnic disparities –which may be a reflection of systematic and structural barriers to appropriate and timely health care – should be a wake-up call for clinicians, payers, legislators, funding agencies, and the overall healthcare system. We need to address worsening trends in heart failure, not only through medical interventions and properly implemented GDMT, but by tackling the growing challenges in health care regarding access and coverage for appropriate and timely care, the effect of mis-incentivization of wrong care such as inappropriate discontinuation of therapies, and social determinants of health that are driving widening disparities.”
Highlights the slowing decline in cardiovascular mortality and increasing prevalence of heart failure in the United States since 2011.
During the first decade of the 21st century, cardiovascular disease (CVD) mortality decreased significantly in the United States, continuing a trend since 1970. However, the rate of decline slowed dramatically in 2011 [(1)][1]. Simultaneously, heart failure (HF) prevalence increased and is projected
No takes yet. Share an insight, caveat, or question.
Glynn et al. (2019) studied this question. Cardiovascular disease mortality in the United States showed a dramatically slowed rate of decline in 2011, coinciding with an increase in heart failure prevalence.
Synapse has enriched 5 related papers. Consider them for comparative context: